Summary

The global organoids market was valued at US$1.28 billion in 2023. The market value is expected to reach US$4.22 billion by 2029. Organoids are three-dimensional (3D) miniature, organ-like structures grown from stem cells that mimic the architecture and function of human organs. Unlike traditional two-dimensional cell cultures, organoids are self-organizing, complex structures that more closely replicate the physiological conditions of actual tissues and organs. This makes them incredibly valuable for studying human development, disease mechanisms, and drug responses.

In the forthcoming years, the organoid market is expected to continue growing due to several converging trends. One key factor is the increasing investment in research and development by pharmaceutical companies and research institutions to leverage organoids for drug discovery and precision medicine applications. The emergence of personalized medicine, which aims to tailor treatments based on individual genetic profiles, has spurred the adoption of organoids, particularly in the field of oncology. Technological advancements in stem cell research, CRISPR gene editing, and bioengineering are also expected to propel the market forward. The market is expected to grow at a CAGR of approx. 22% during the forecasted period of 2024-2029.

Market Segmentation Analysis:

By Organ Type: The report provides the bifurcation of the global organoids market based on the organ type: Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others. The intestine segment held the highest share of the market, whereas stomach segment is expected to be the fastest-growing segment in the forecasted period. The organoid market for intestinal models is experiencing significant growth due to the increasing prevalence of gastrointestinal diseases and disorders, such as inflammatory bowel disease (IBD), colorectal cancer, and celiac disease. Organoids derived from intestinal stem cells closely mimic the architecture and functionality of the human intestine, providing an ideal platform for studying disease mechanisms, drug responses, and microbiome interactions. On the other hand, stomach organoids provide a powerful tool for researchers to model gastric physiology and pathophysiology, enabling the study of disease mechanisms and the development of new therapeutic strategies. These organoids can be used to investigate the effects of specific diets and dietary components on gastric health, which is crucial given the increasing awareness of the role nutrition plays in preventing and managing gastric disorders.

By Application: The report provide the bifurcation of global organoids market based on the following application: Developmental Biology Disease, Drug Discovery and Personalized Medicine, Regenerative Medicine, Pathology of Infectious Disease, Drug Toxicity and Efficacy Testing, and Others. The developmental biology disease segment held the highest share of the market, whereas the drug discovery and personalized medicine segment is expected to be the fastest-growing segment in the forecasted period. The demand for organoids in developmental biology is increasing due to their ability to provide valuable insights into the mechanisms of organogenesis and the developmental processes underlying various diseases. Organoids, derived from stem cells, closely mimic the architecture and functionality of actual organs, allowing researchers to study how tissues develop and how genetic and environmental factors can influence these processes. On the other hand, the rising demand for organoids in drug discovery and personalized medicine is primarily attributed to their potential to enhance the efficacy and safety of therapeutic interventions. Organoids can be generated from patient-specific cells, allowing for the development of models that closely resemble an individual’s unique biology. This capability enables researchers to perform drug screening and assess the effectiveness of various compounds in a personalized context, thus providing insights into how different patients may respond to treatments.

By Source: The report provides the glimpse of the global organoids market based on the following sources: Pluripotent Stem Cells and Organ-specific Adult Stem Cells. Pluripotent stem cells held the highest share of the market and is expected to be the fastest-growing segment in the forecasted period. The demand for organoids derived from pluripotent stem cells is experiencing significant growth due to their remarkable potential to differentiate into virtually any cell type in the human body. Pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells (iPSCs), provide a versatile platform for generating organoids that closely mimic the structure and function of various organs. This capability is particularly advantageous in the field of regenerative medicine, where the ability to produce patient-specific organoids can facilitate personalized treatment strategies and enhance the understanding of disease mechanisms.

By Type: Based on type, the market can be bifurcated into three segments: Consumables, Instruments, and Services. Consumables held the highest share of the market and is expected to be the fastest-growing segment in the forecasted period. The demand for consumables in the organoid market is experiencing growth due to their crucial role in supporting organoid development, maintenance, and experimentation. Consumables such as culture media, growth factors, extracellular matrices, reagents, and specialized supplements are essential for creating and sustaining organoid cultures. As research and clinical applications involving organoids continue to expand, the need for high-quality consumables that ensure the proper growth, differentiation, and functionality of organoids is increasing.

By End-User: On the basis of end-user, the global organoids market can be divided into four segments namely, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, Hospitals and Diagnostic Centers, and Other End-Users. Biotechnology and pharmaceutical companies held the highest share of the market and is expected to be the fastest-growing segment in the forecasted period. The demand for organoids among biotechnology and pharmaceutical companies is rapidly increasing due to their potential to revolutionize drug discovery, development, and personalized medicine. Organoids offer these companies highly accurate, human-relevant models for testing drug efficacy, toxicity, and disease mechanisms, which can significantly reduce the reliance on animal models and 2D cell cultures that often fail to predict human responses.

By Region: The report provides insight into the organoids market based on the regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the major share of the market. In the US, the growth of the organoid market has been particularly pronounced due to several factors. First, the country has the largest pharmaceutical and biotechnology sectors in the world, with substantial investment in R&D aimed at improving drug discovery and precision medicine. The US government, through agencies like the National Institutes of Health (NIH), has been heavily funding research on organoids, boosting their development and adoption. The country’s advanced healthcare system, which emphasizes early disease detection and personalized treatment, further accelerates the demand for innovative organoid-based solutions.

Germany has emerged as a leader in the European organoid market due to its strong biotechnology sector, robust healthcare infrastructure, and heavy investment in medical research. The country is renowned for its advanced research institutions, such as the Max Planck Institute and Helmholtz Association, which are at the forefront of stem cell and organoid research. Germany’s commitment to innovation is further bolstered by significant government funding, such as through the Federal Ministry of Education and Research (BMBF), supporting initiatives in regenerative medicine and biotechnology.

China, as one of the leading markets in the Asia Pacific, has been experiencing a surge in organoid research and applications, driven by the country’s ambitious healthcare reforms and strong focus on biotechnology innovation. The Chinese government has made significant investments in biomedical research through initiatives like “Made in China 2025,” which emphasizes advancements in biotechnology and healthcare innovation. China’s vast pharmaceutical industry is increasingly integrating organoid technology into its drug discovery pipeline to reduce the reliance on animal testing and improve the accuracy of preclinical drug trials.

Market Dynamics:

Growth Drivers: The global organoids market has been growing over the past few years, due to factors such as increasing demand for tumor modeling and biobanking, growing adoption of personalized drugs, rising focus on developing alternatives for animal testing models, advancements in stem cell research, rising investment in research and development (R&D), growing adoption in toxicology testing, growing collaborations and partnerships, and many other factors. Advancements in stem cell research are pivotal to the growth of the organoid market, as they enable the development of more complex and physiologically accurate organoid models. Stem cells, particularly induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), have the unique ability to differentiate into various cell types, allowing scientists to generate organ-specific tissues that closely mimic human organs. With the progress in stem cell technology, researchers are now able to create organoids that replicate the structure and function of organs like the brain, liver, lungs, and kidneys with greater precision. These advancements have expanded the applications of organoids in drug discovery, disease modeling, personalized medicine, and regenerative therapies.

Challenges: However, the market growth would be negatively impacted by various challenges such as lack of skilled professionals, issues related to incorporation of organoid into existing workforce, etc.

Trends: The market is projected to grow at a fast pace during the forecast period, due to increasing focus on drug discovery and development, combining organoid with organ-on-a-chip, advancement in biotechnology, technological innovations in 3D cell culture, etc. Organoid and organ-on-a-chip, which serve as evolving pathological and human physiological relevant in vitro models, have the potential to revolutionize the conventional paradigm of cancer research and produce real clinical benefits. The recent inclination in the collaborative application of organoids with organ-on-a-chip and 3D bioprinting enables the development of sophisticated cancer models to study underlying mechanisms of tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment interactions. By incorporating multiple organoids into organ-on-a-chip, organoid-on-a-chip can inherit benefits of both organoid and organ-on-a-chip and provide a valuable tool to study multiorgan tumor metastases and cancer-microenvironment interactions.

Impact Analysis of COVID-19 and Way Forward:

While the pandemic initially created operational challenges, it ultimately accelerated the adoption and validation of organoids as a key tool in biomedical research, leading to greater investment and interest in their applications beyond COVID-19. The post-pandemic era has seen the organoids market thrive, benefiting from increased investment, technological innovation, and the broader recognition of their value in both therapeutic development and disease modeling.

Competitive Landscape:

The global organoids market is fragmented in nature. The key players in the global organoids market are:

Danaher Corporation (Molecular Devices, LLC)
Thermo Fisher Scientific Inc.
Merck Group
Corning Incorporated
Charles River Laboratories International, Inc.
DefiniGEN Limited
InSphero
STEMCELL Technologies
HUB Organoids
Mimetas
Organoid Therapeutics
3Dnamics

ページTOPに戻る

Table of Contents

1. Executive Summary

2. Introduction

2.1 Organoids: An Overview
2.1.1 Introduction to Organoids

2.2 Organoids Segmentation: An Overview

3. Global Market Analysis

3.1 Global Organoids Market: An Analysis

3.1.1 Global Organoids Market: An Overview
3.1.2 Global Organoids Market by Value
3.1.3 Global Organoids Market by Organ Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others)
3.1.4 Global Organoids Market by Application (Developmental Biology Disease, Drug Discovery and Personalized Medicine, Regenerative Medicine, Pathology of Infectious Disease, Drug Toxicity and Efficacy Testing, and Others)
3.1.5 Global Organoids Market by Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
3.1.6 Global Organoids Market by Type (Consumables, Instruments, and Services)
3.1.7 Global Organoids Market by End-User (Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, Hospitals and Diagnostic Centers, and Other End-Users)
3.1.8 Global Organoids Market by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

3.2 Global Organoids Market: Organ Type Analysis

3.2.1 Global Organoids Market by Organ Type: An Overview
3.2.2 Global Intestine Organoids Market by Value
3.2.3 Global Liver Organoids Market by Value
3.2.4 Global Stomach Organoids Market by Value
3.2.5 Global Pancreas Organoids Market by Value
3.2.6 Global Lung Organoids Market by Value
3.2.7 Global Brain Organoids Market by Value
3.2.8 Global Kidney Organoids Market by Value
3.2.9 Global Others Organoids Market by Value

3.3 Global Organoids Market: Application Analysis

3.3.1 Global Organoids Market by Application: An Overview
3.3.2 Global Organoids Developmental Biology Disease Market by Value
3.3.3 Global Organoids Drug Discovery and Personalized Medicine Market by Value
3.3.4 Global Organoids Regenerative Medicine Market by Value
3.3.5 Global Organoids Pathology of Infectious Disease Market by Value
3.3.6 Global Organoids Drug Toxicity and Efficacy Testing Market by Value
3.3.7 Global Others Organoids Market by Value

3.4 Global Organoids Market: Source Analysis

3.4.1 Global Organoids Market by Source: An Overview
3.4.2 Global Pluripotent Stem Cells Organoids Market by Value
3.4.3 Global Organ-Specific Adult Stem Cells Organoids Market by Value

3.5 Global Organoids Market: Type Analysis

3.5.1 Global Organoids Market by Type: An Overview
3.5.2 Global Organoids Consumables Market by Value
3.5.3 Global Organoids Instruments Market by Value
3.5.4 Global Organoids Services Market by Value

3.6 Global Organoids Market: End-User Analysis

3.6.1 Global Organoids Market by End-User: An Overview
3.6.2 Global Biotechnology and Pharmaceutical Companies Organoids Market by Value
3.6.3 Global Academic and Research Institutes Organoids Market by Value
3.6.4 Global Hospitals and Diagnostic Centers Organoids Market by Value
3.6.5 Global Other End-Users Organoids Market by Value

4. Regional Market Analysis

4.1 North America Organoids Market: An Analysis

4.1.1 North America Organoids Market: An Overview
4.1.2 North America Organoids Market by Value
4.1.3 North America Organoids Market by Region (The US, Canada, and Mexico)
4.1.4 The US Organoids Market by Value
4.1.5 Canada Organoids Market by Value
4.1.6 Mexico Organoids Market by Value

4.2 Europe Organoids Market: An Analysis

4.2.1 Europe Organoids Market: An Overview
4.2.2 Europe Organoids Market by Value
4.2.3 Europe Organoids Market by Region (Germany, The UK, France, Italy, Spain, and Rest of the Europe)
4.2.4 Germany Organoids Market by Value
4.2.5 The UK Organoids Market by Value
4.2.6 France Organoids Market by Value
4.2.7 Italy Organoids Market by Value
4.2.8 Spain Organoids Market by Value
4.2.9 Rest of Europe Organoids Market by Value

4.3 Asia Pacific Organoids Market: An Analysis

4.3.1 Asia Pacific Organoids Market: An Overview
4.3.2 Asia Pacific Organoids Market by Value
4.3.3 Asia Pacific Organoids Market by Region (China, Japan, India, South Korea, and Rest of the Asia Pacific)
4.3.4 China Organoids Market by Value
4.3.5 Japan Organoids Market by Value
4.3.6 India Organoids Market by Value
4.3.7 South Korea Organoids Market by Value
4.3.8 Rest of Asia Pacific Organoids Market by Value

4.4 Latin America Organoids Market: An Analysis

4.4.1 Latin America Organoids Market: An Overview
4.4.2 Latin America Organoids Market by Value

4.5 Middle East & Africa Organoids Market: An Analysis

4.5.1 Middle East & Africa Organoids Market: An Overview
4.5.2 Middle East & Africa Organoids Market by Value

5. Impact of COVID-19

5.1 Impact of COVID-19 on Global Organoids Market
5.2 Post COVID-19 Impact on Global Organoids Market

6. Market Dynamics

6.1 Growth Drivers
6.1.1 Increasing Demand for Tumor Modeling and Biobanking
6.1.2 Growing Adoption of Personalized Drugs
6.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
6.1.4 Advancements in Stem Cell Research
6.1.5 Rising Investment in Research and Development (R&D)
6.1.6 Growing Adoption in Toxicology Testing
6.1.7 Growing Collaborations and Partnerships

6.2 Challenges
6.2.1 Lack of Skilled Professionals
6.2.2 Issues Related to Incorporation of Organoid into Existing Workforce

6.3 Market Trends
6.3.1 Increasing Focus on Drug Discovery and Development
6.3.2 Combining Organoid with Organ-On-A-Chip
6.3.3 Advancement in Biotechnology
6.3.4 Technological Innovations in 3D Cell Culture

7. Competitive Landscape

7.1 Global Organoids Market: Competitive Landscape
7.2 Global Organoids Market: Product Comparison

8. Company Profiles

8.1 Danaher Corporation (Molecular Devices, LLC)
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy

8.2 Thermo Fisher Scientific Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy

8.3 Merck Group
8.3.1 Business Overview
8.3.2 Net Sales by Business Sector
8.3.3 Business Strategy

8.4 Corning Incorporated
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy

8.5 Charles River Laboratories International, Inc.
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy

8.6 DefiniGEN Limited
8.6.1 Business Overview
8.6.2 Business Strategy

8.7 InSphero
8.7.1 Business Overview
8.7.2 Business Strategy

8.8 STEMCELL Technologies
8.8.1 Business Overview
8.8.2 Business Strategy

8.9 HUB Organoids
8.9.1 Business Overview
8.9.2 Business Strategy

8.10 Mimetas
8.10.1 Business Overview
8.10.2 Business Strategy

8.11 Organoid Therapeutics
8.11.1 Business Overview

8.12 3Dnamics
8.12.1 Business Overview

List of Figures

Figure 1: Organoids Segmentation
Figure 2: Global Organoids Market by Value; 2019-2023 (US$ Million)
Figure 3: Global Organoids Market by Value; 2024-2029 (US$ Billion)
Figure 4: Global Organoids Market by Organ Type; 2023 (Percentage, %)
Figure 5: Global Organoids Market by Application; 2023 (Percentage, %)
Figure 6: Global Organoids Market by Source; 2023 (Percentage, %)
Figure 7: Global Organoids Market by Type; 2023 (Percentage, %)
Figure 8: Global Organoids Market by End-User; 2023 (Percentage, %)
Figure 9: Global Organoids Market by Region; 2023 (Percentage, %)
Figure 10: Global Intestine Organoids Market by Value; 2019-2023 (US$ Million)
Figure 11: Global Intestine Organoids Market by Value; 2024-2029 (US$ Million)
Figure 12: Global Liver Organoids Market by Value; 2019-2023 (US$ Million)
Figure 13: Global Liver Organoids Market by Value; 2024-2029 (US$ Million)
Figure 14: Global Stomach Organoids Market by Value; 2019-2023 (US$ Million)
Figure 15: Global Stomach Organoids Market by Value; 2024-2029 (US$ Million)
Figure 16: Global Pancreas Organoids Market by Value; 2019-2023 (US$ Million)
Figure 17: Global Pancreas Organoids Market by Value; 2024-2029 (US$ Million)
Figure 18: Global Lung Organoids Market by Value; 2019-2023 (US$ Million)
Figure 19: Global Lung Organoids Market by Value; 2024-2029 (US$ Million)
Figure 20: Global Brain Organoids Market by Value; 2019-2023 (US$ Million)
Figure 21: Global Brain Organoids Market by Value; 2024-2029 (US$ Million)
Figure 22: Global Kidney Organoids Market by Value; 2019-2023 (US$ Million)
Figure 23: Global Kidney Organoids Market by Value; 2024-2029 (US$ Million)
Figure 24: Global Others Organoids Market by Value; 2019-2023 (US$ Million)
Figure 25: Global Others Organoids Market by Value; 2024-2029 (US$ Million)
Figure 26: Global Organoids Developmental Biology Disease Market by Value; 2019-2023 (US$ Million)
Figure 27: Global Organoids Developmental Biology Disease Market by Value; 2024-2029 (US$ Million)
Figure 28: Global Organoids Drug Discovery and Personalized Medicine Market by Value; 2019-2023 (US$ Million)
Figure 29: Global Organoids Drug Discovery and Personalized Medicine Market by Value; 2024-2029 (US$ Million)
Figure 30: Global Organoids Regenerative Medicine Market by Value; 2019-2023 (US$ Million)
Figure 31: Global Organoids Regenerative Medicine Market by Value; 2024-2029 (US$ Million)
Figure 32: Global Organoids Pathology of Infectious Disease Market by Value; 2019-2023 (US$ Million)
Figure 33: Global Organoids Pathology of Infectious Disease Market by Value; 2024-2029 (US$ Million)
Figure 34: Global Organoids Drug Toxicity and Efficacy Testing Market by Value; 2019-2023 (US$ Million)
Figure 35: Global Organoids Drug Toxicity and Efficacy Testing Market by Value; 2024-2029 (US$ Million)
Figure 36: Global Others Organoids Market by Value; 2019-2023 (US$ Million)
Figure 37: Global Others Organoids Market by Value; 2024-2029 (US$ Million)
Figure 38: Global Pluripotent Stem Cells Organoids Market by Value; 2019-2023 (US$ Million)
Figure 39: Global Pluripotent Stem Cells Organoids Market by Value; 2024-2029 (US$ Billion)
Figure 40: Global Organ-Specific Adult Stem Cells Organoids Market by Value; 2019-2023 (US$ Million)
Figure 41: Global Organ-Specific Adult Stem Cells Organoids Market by Value; 2024-2029 (US$ Million)
Figure 42: Global Organoids Consumables Market by Value; 2019-2023 (US$ Million)
Figure 43: Global Organoids Consumables Market by Value; 2024-2029 (US$ Billion)
Figure 44: Global Organoids Instruments Market by Value; 2019-2023 (US$ Million)
Figure 45: Global Organoids Instruments Market by Value; 2024-2029 (US$ Million)
Figure 46: Global Organoids Services Market by Value; 2019-2023 (US$ Million)
Figure 47: Global Organoids Services Market by Value; 2024-2029 (US$ Million)
Figure 48: Global Biotechnology and Pharmaceutical Companies Organoids Market by Value; 2019-2023 (US$ Million)
Figure 49: Global Biotechnology and Pharmaceutical Companies Organoids Market by Value; 2024-2029 (US$ Billion)
Figure 50: Global Academic and Research Institutes Organoids Market by Value; 2019-2023 (US$ Million)
Figure 51: Global Academic and Research Institutes Organoids Market by Value; 2024-2029 (US$ Million)
Figure 52: Global Organoids Hospitals and Diagnostic Centers Market by Value; 2019-2023 (US$ Million)
Figure 53: Global Organoids Hospitals and Diagnostic Centers Market by Value; 2024-2029 (US$ Million)
Figure 54: Global Organoids Other End-Users Market by Value; 2019-2023 (US$ Million)
Figure 55: Global Organoids Other End-Users Market by Value; 2024-2029 (US$ Million)
Figure 56: North America Organoids Market by Value; 2019-2023 (US$ Million)
Figure 57: North America Organoids Market by Value; 2024-2029 (US$ Billion)
Figure 58: North America Organoids Market by Region; 2023 (Percentage, %)
Figure 59: The US Organoids Market by Value; 2019-2023 (US$ Million)
Figure 60: The US Organoids Market by Value; 2024-2029 (US$ Million)
Figure 61: Canada Organoids Market by Value; 2019-2023 (US$ Million)
Figure 62: Canada Organoids Market by Value; 2024-2029 (US$ Million)
Figure 63: Mexico Organoids Market by Value; 2019-2023 (US$ Million)
Figure 64: Mexico Organoids Market by Value; 2024-2029 (US$ Million)
Figure 65: Europe Organoids Market by Value; 2019-2023 (US$ Million)
Figure 66: Europe Organoids Market by Value; 2024-2029 (US$ Million)
Figure 67: Europe Organoids Market by Region; 2023 (Percentage, %)
Figure 68: Germany Organoids Market by Value; 2019-2023 (US$ Million)
Figure 69: Germany Organoids Market by Value; 2024-2029 (US$ Million)
Figure 70: The UK Organoids Market by Value; 2019-2023 (US$ Million)
Figure 71: The UK Organoids Market by Value; 2024-2029 (US$ Million)
Figure 72: France Organoids Market by Value; 2019-2023 (US$ Million)
Figure 73: France Organoids Market by Value; 2024-2029 (US$ Million)
Figure 74: Italy Organoids Market by Value; 2019-2023 (US$ Million)
Figure 75: Italy Organoids Market by Value; 2024-2029 (US$ Million)
Figure 76: Spain Organoids Market by Value; 2019-2023 (US$ Million)
Figure 77: Spain Organoids Market by Value; 2024-2029 (US$ Million)
Figure 78: Rest of Europe Organoids Market by Value; 2019-2023 (US$ Million)
Figure 79: Rest of Europe Organoids Market by Value; 2024-2029 (US$ Million)
Figure 80: Asia Pacific Organoids Market by Value; 2019-2023 (US$ Million)
Figure 81: Asia Pacific Organoids Market by Value; 2024-2029 (US$ Million)
Figure 82: Asia Pacific Organoids Market by Region; 2023 (Percentage, %)
Figure 83: China Organoids Market by Value; 2019-2023 (US$ Million)
Figure 84: China Organoids Market by Value; 2024-2029 (US$ Million)
Figure 85: Japan Organoids Market by Value; 2019-2023 (US$ Million)
Figure 86: Japan Organoids Market by Value; 2024-2029 (US$ Million)
Figure 87: India Organoids Market by Value; 2019-2023 (US$ Million)
Figure 88: India Organoids Market by Value; 2024-2029 (US$ Million)
Figure 89: South Korea Organoids Market by Value; 2019-2023 (US$ Million)
Figure 90: South Korea Organoids Market by Value; 2024-2029 (US$ Million)
Figure 91: Rest of Asia Pacific Organoids Market by Value; 2019-2023 (US$ Million)
Figure 92: Rest of Asia Pacific Organoids Market by Value; 2024-2029 (US$ Million)
Figure 93: Latin America Organoids Market by Value; 2019-2023 (US$ Million)
Figure 94: Latin America Organoids Market by Value; 2024-2029 (US$ Million)
Figure 95: Middle East & Africa Organoids Market by Value; 2019-2023 (US$ Million)
Figure 96: Middle East & Africa Organoids Market by Value; 2024-2029 (US$ Million)
Figure 97: Danaher Corporation Revenue by Segment; 2023 (Percentage, %)
Figure 98: Thermo Fisher Scientific Inc. Revenue by Segment; 2023 (Percentage, %)
Figure 99: Merck Group Net Sales by Business Sector; 2023 (Percentage, %)
Figure 100: Corning Incorporated Net Sales by Segment; 2023 (Percentage, %)
Figure 101: Charles River Laboratories International, Inc. Revenue by Segment; 2023 (Percentage, %)
Table 1: Global Organoids Market: Product Comparison